Alliancebernstein L.P. Merus N.V. Transaction History
Alliancebernstein L.P.
- $280 Billion
- Q4 2024
A detailed history of Alliancebernstein L.P. transactions in Merus N.V. stock. As of the latest transaction made, Alliancebernstein L.P. holds 796,957 shares of MRUS stock, worth $32.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
796,957
Previous 730,631
9.08%
Holding current value
$32.1 Million
Previous $36.5 Million
8.19%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding MRUS
# of Institutions
198Shares Held
62.3MCall Options Held
243KPut Options Held
220K-
Rtw Investments, LP New York, NY4.17MShares$168 Million3.32% of portfolio
-
Wellington Management Group LLP Boston, MA3.5MShares$141 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.41MShares$137 Million3.17% of portfolio
-
Commodore Capital LP New York, NY3.35MShares$135 Million14.22% of portfolio
-
Samlyn Capital, LLC New York, NY2.61MShares$105 Million2.1% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.85B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...